The side-by-side comparison tool provides a quick overview of former President Trump’s and President Biden’s records, positions, public statements, and proposed policies on a range of key health care topics.
Category: Medicare
Medicaid for Millions in America Hinges on Deloitte-Run Systems Plagued by Errors
The technology has generated notices with errors, sent Medicaid paperwork to the wrong addresses, and been frozen for hours at a time, according to state audits, court documents, and interviews. While it can take months to fix problems, America’s poorest residents pay the price.
Medicaid for Millions in America Hinges on Deloitte-Run Systems Plagued by Errors
The technology has generated notices with errors, sent Medicaid paperwork to the wrong addresses, and been frozen for hours at a time, according to state audits, court documents, and interviews. While it can take months to fix problems, America’s poorest residents pay the price.
KFF Health News’ ‘What the Health?’: Live From Aspen: Health and the 2024 Elections
Health policy may not be the top issue in this year’s presidential and congressional elections, but it’s likely to play a key role. President Joe Biden and Democrats intend to hold Republicans responsible for the Supreme Court’s unpopular ruling overturning the right to abortion, and former President Donald Trump aims to take credit for government efforts to lower prescription drug prices — even in cases in which he played no role. Meanwhile, some critical health care issues, such as those involving Medicaid and the Affordable Care Act, are unlikely to get discussed much, even though the party in power after the elections would control the future of those programs. This week, in an episode taped before a live audience at the Aspen Ideas: Health festival in Aspen, Colorado, Margot Sanger-Katz of The New York Times and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more.
Older Women Are Different Than Older Men. Their Health Is Woefully Understudied.
The White House has launched an initiative on women’s health. Studying the health of older women, a largely neglected group in medical research, should be a priority.
Five Things to Know About Medicare Site-Neutral Payment Reforms
This brief examines key facts around proposals to align Medicare payments for outpatient services across care settings, otherwise known as “site-neutral payment reforms.”
KFF Health News’ ‘What the Health?’: SCOTUS Rejects Abortion Pill Challenge — For Now
The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.
The Facts About the $35 Insulin Copay Cap in Medicare
This brief describes the facts about actions taken under both the Trump and Biden Administrations related to capping insulin copayments for people with Medicare and explains the differences between their approaches.
Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.
Biden Plan to Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.
